Lenacapavir: an attractive option, but proceed with caution

Lancet HIV. 2023 Aug;10(8):e486-e487. doi: 10.1016/S2352-3018(23)00170-4. Epub 2023 Jul 11.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-HIV Agents* / adverse effects
  • HIV Infections* / drug therapy
  • Humans

Substances

  • Anti-HIV Agents